Major Biotech Merger: Protagenic and Phytanix Unite to Challenge GLP-1 Market With Novel Obesity Treatment

Mergers & acquisitions News

Protagenic Therapeutics (NASDAQ: PTIX) and Phytanix Bio have agreed to merge in an all-stock transaction to form Phytanix, Inc., creating a ...